Nature Reviews Drug Discovery-各期论文-万方医学网

首页 > 期刊 > Nature Reviews Drug ...

Nature Reviews Drug Discovery Nature Reviews Drug Discovery

CA ·

查看本刊信息收藏

2017年第16卷09期

共18篇

6. Remyelination therapies: a new direction and challenge in multiple sclerosis 617-634页

作者：Plemel, Jason R.； Liu, Wei-Qiao； Yong, V. Wee

NSTL

7. IL-2 focus switches to stimulating T-regs 595-595页

作者：Cully, Megan

NSTL

8. ANTIBACTERIAL AGENTS New routes to tuberculosis treatment 600-600页

作者：Crunkhorn, Sarah

NSTL

9. Structural and procedural characteristics of international regulatory authorities 594-+页

作者：Jain, Anand B.； Mollet, Annette； Szucs, Thomas D.

NSTL

10. BIOTECHNOLOGY CRISPR-Cas becoming more human 601-601页

作者：Baumann, Kim

NSTL

11. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors (vol 16, pg 1, 2017) 661-661页

作者：Hutchings, Catherine J.； Koglin, Markus； Olson, William C.； Marshall, Fiona H.

NSTL

12. Nigel Blackburn 596-596页

作者：Mullard, Asher； Blackburn, Nigel

NSTL

13. INFLAMMATORY DISEASES An IL-9 solution to inflammation resolution

作者：Cully, Megan

NSTL

14. FDA rejects first-in-class osteoporosis drug 593-593页

作者：Mullard, Asher

NSTL

15. FDA OKs first in vitro route to expanded approval 591-592页

作者：Kingwell, Katie

NSTL

16. FDA approves first-in-class cancer metabolism drug 593-593页

作者：Mullard, Asher

NSTL

17. The antifungal pipeline: a reality check 603-616页

作者：Perfect, John R.

NSTL

18. Diabetes drug shows promise in Parkinson disease 593-593页

作者：Mullard, Asher

NSTL

检索历史清除

Nature Reviews Drug Discovery Nature Reviews Drug Discovery

各期导航

2017年

2017年第16卷09期

1. CANCER Ironing it out 602-602页

2. What is the right amount to spend on biopharma R&D? 597-598页

3. Synthetic lethality screens point the way to new cancer drug targets 589-+页

4. Therapeutic targeting of the angiopoietin-TIE pathway 635-+页

5. CANCER IMMUNOTHERAPY Searching in the immune checkpoint black box 599-599页

6. Remyelination therapies: a new direction and challenge in multiple sclerosis 617-634页

7. IL-2 focus switches to stimulating T-regs 595-595页

8. ANTIBACTERIAL AGENTS New routes to tuberculosis treatment 600-600页

9. Structural and procedural characteristics of international regulatory authorities 594-+页

10. BIOTECHNOLOGY CRISPR-Cas becoming more human 601-601页

11. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors (vol 16, pg 1, 2017) 661-661页

12. Nigel Blackburn 596-596页

13. INFLAMMATORY DISEASES An IL-9 solution to inflammation resolution

14. FDA rejects first-in-class osteoporosis drug 593-593页

15. FDA OKs first in vitro route to expanded approval 591-592页

16. FDA approves first-in-class cancer metabolism drug 593-593页

17. The antifungal pipeline: a reality check 603-616页

18. Diabetes drug shows promise in Parkinson disease 593-593页

检索历史 清除

Nature Reviews Drug Discovery Nature Reviews Drug Discovery

各期导航

2017年

2017年第16卷09期

1. CANCER Ironing it out 602-602页

2. What is the right amount to spend on biopharma R&D? 597-598页

3. Synthetic lethality screens point the way to new cancer drug targets 589-+页

4. Therapeutic targeting of the angiopoietin-TIE pathway 635-+页

5. CANCER IMMUNOTHERAPY Searching in the immune checkpoint black box 599-599页

6. Remyelination therapies: a new direction and challenge in multiple sclerosis 617-634页

7. IL-2 focus switches to stimulating T-regs 595-595页

8. ANTIBACTERIAL AGENTS New routes to tuberculosis treatment 600-600页

9. Structural and procedural characteristics of international regulatory authorities 594-+页

10. BIOTECHNOLOGY CRISPR-Cas becoming more human 601-601页

11. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors (vol 16, pg 1, 2017) 661-661页

12. Nigel Blackburn 596-596页

13. INFLAMMATORY DISEASES An IL-9 solution to inflammation resolution

14. FDA rejects first-in-class osteoporosis drug 593-593页

15. FDA OKs first in vitro route to expanded approval 591-592页

16. FDA approves first-in-class cancer metabolism drug 593-593页

17. The antifungal pipeline: a reality check 603-616页

18. Diabetes drug shows promise in Parkinson disease 593-593页

检索历史清除